Thomas Michael Perone
First SEC filing: Jan. 2, 2020 · Latest: Jan. 2, 2020
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 22, 2024 | OVID | A | 168,750 | · | · | 168,750 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 22, 2024 | OVID | A | 28,125 | · | · | 28,125 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 23, 2023 | OVID | A | 175,000 | · | · | 175,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 8, 2022 | OVID | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 8, 2022 | OVID | A | 25,399 | · | · | 25,399 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 3, 2022 | OVID | A | 175,000 | · | · | 175,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 17, 2020 | OVID | A | 175,000 | · | · | 175,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 25, 2020 | OVID | A | 44,000 | · | · | 44,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 11, 2020 | OVID | A | 20,000 | · | · | 20,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 1, 2020 | OVID | A | 75,000 | · | · | 75,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 18, 2019 | OVID | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 3, 2019 | OVID | A | 125,000 | · | · | 125,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 22, 2024 | OVID | Stock Option (Right to Buy) | Common Stock | $3.68 | Feb. 21, 2034 | 168,750 | Acquired |
| Feb. 23, 2023 | OVID | Stock Option (Right to Buy) | Common Stock | $2.50 | Feb. 22, 2033 | 175,000 | Acquired |
| April 8, 2022 | OVID | Stock Option (Right to Buy) | Common Stock | $3.22 | April 7, 2032 | 10,000 | Acquired |
| April 8, 2022 | OVID | Stock Option (Right to Buy) | Common Stock | $3.22 | April 7, 2032 | 25,399 | Acquired |
| Feb. 3, 2022 | OVID | Stock Option (Right to Buy) | Common Stock | $2.72 | Feb. 2, 2032 | 175,000 | Acquired |
| Dec. 17, 2020 | OVID | Stock Option (Right to Buy) | Common Stock | $2.82 | Dec. 16, 2030 | 175,000 | Acquired |
| Nov. 25, 2020 | OVID | Stock Option (Right to Buy) | Common Stock | $3.66 | May 4, 2030 | 44,000 | Acquired |
| Oct. 11, 2020 | OVID | Stock Option (Right to Buy) | Common Stock | $5.65 | Oct. 10, 2030 | 20,000 | Acquired |
| Jan. 1, 2020 | OVID | Stock Option (Right to Buy) | Common Stock | $4.15 | Dec. 31, 2030 | 75,000 | Acquired |
| Dec. 18, 2019 | OVID | Stock Option (Right to Buy) | Common Stock | $4.42 | Dec. 17, 2029 | 100,000 | Acquired |
| April 3, 2019 | OVID | Employee Stock Option (Right to Buy) | Common Stock | $1.92 | March 24, 2029 | 125,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $494,940 | · | · | · | $237,571 | · | $13,200 | $1,068,446 |
| 2021 | $457,600 | · | · | · | $162,906 | · | $11,600 | $638,077 |
| 2020 | $440,000 | · | · | $842,145 | $176,000 | · | $17,371 | $1,475,516 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.